[器官受限的肌肉浸润性膀胱癌的三模式器官保留治疗]。

Q4 Medicine
Magyar onkologia Pub Date : 2021-12-07 Epub Date: 2021-11-30
Péter Ágoston, Kliton Jorgo, Zsuzsa S Kocsis, Levente Varga, László Gesztesi, Zoltán Takácsi-Nagy, Csaba Polgár
{"title":"[器官受限的肌肉浸润性膀胱癌的三模式器官保留治疗]。","authors":"Péter Ágoston,&nbsp;Kliton Jorgo,&nbsp;Zsuzsa S Kocsis,&nbsp;Levente Varga,&nbsp;László Gesztesi,&nbsp;Zoltán Takácsi-Nagy,&nbsp;Csaba Polgár","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Radical cystectomy is the gold standard treatment in localized muscle-invasive bladder cancer according to today's guidelines. However, in many cases, surgery is not possible due to the patient's general condition, or the patient refuses bladder removal. In such cases, as well as in some selected patients suitable for surgery, trimodal organ preservation therapy is an alternative, which provides the patient with similar survival, local tumor control, so that 80% of patients retain their bladder. In some cases, due to complications or a muscle-invasive local recurrence in the bladder, the bladder may not be retained. At this point, a salvage cystectomy can still save the patient's quality of life and life. Adequate patient selection is a prerequisite for effective trimodal therapy. We summarize the components of organ-preserving treatment, including radiation therapy, its state-of-the-art technology, results and side effects. The results and toxicity of trimodal treatment are compared with those of radical cystectomy.</p>","PeriodicalId":18175,"journal":{"name":"Magyar onkologia","volume":"65 4","pages":"319-328"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Trimodal, organ-preserving treatment of organ-confined, muscle-invasive bladder cancer].\",\"authors\":\"Péter Ágoston,&nbsp;Kliton Jorgo,&nbsp;Zsuzsa S Kocsis,&nbsp;Levente Varga,&nbsp;László Gesztesi,&nbsp;Zoltán Takácsi-Nagy,&nbsp;Csaba Polgár\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Radical cystectomy is the gold standard treatment in localized muscle-invasive bladder cancer according to today's guidelines. However, in many cases, surgery is not possible due to the patient's general condition, or the patient refuses bladder removal. In such cases, as well as in some selected patients suitable for surgery, trimodal organ preservation therapy is an alternative, which provides the patient with similar survival, local tumor control, so that 80% of patients retain their bladder. In some cases, due to complications or a muscle-invasive local recurrence in the bladder, the bladder may not be retained. At this point, a salvage cystectomy can still save the patient's quality of life and life. Adequate patient selection is a prerequisite for effective trimodal therapy. We summarize the components of organ-preserving treatment, including radiation therapy, its state-of-the-art technology, results and side effects. The results and toxicity of trimodal treatment are compared with those of radical cystectomy.</p>\",\"PeriodicalId\":18175,\"journal\":{\"name\":\"Magyar onkologia\",\"volume\":\"65 4\",\"pages\":\"319-328\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Magyar onkologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/11/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Magyar onkologia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/11/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

根据今天的指南,根治性膀胱切除术是局部肌肉浸润性膀胱癌的金标准治疗。然而,在许多情况下,由于患者的一般情况,手术是不可能的,或者患者拒绝膀胱切除。在这种情况下,以及在一些选择适合手术的患者中,三模态器官保存治疗是一种选择,它为患者提供了相似的生存率,局部肿瘤控制,使80%的患者保留了膀胱。在某些情况下,由于并发症或膀胱肌肉侵袭性局部复发,膀胱可能不保留。此时,补救性膀胱切除术仍可挽救患者的生活质量和生命。充分的患者选择是有效的三模式治疗的先决条件。我们总结了器官保存治疗的组成部分,包括放射治疗,其最新技术,结果和副作用。比较了三模式治疗与根治性膀胱切除术的疗效和毒性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Trimodal, organ-preserving treatment of organ-confined, muscle-invasive bladder cancer].

Radical cystectomy is the gold standard treatment in localized muscle-invasive bladder cancer according to today's guidelines. However, in many cases, surgery is not possible due to the patient's general condition, or the patient refuses bladder removal. In such cases, as well as in some selected patients suitable for surgery, trimodal organ preservation therapy is an alternative, which provides the patient with similar survival, local tumor control, so that 80% of patients retain their bladder. In some cases, due to complications or a muscle-invasive local recurrence in the bladder, the bladder may not be retained. At this point, a salvage cystectomy can still save the patient's quality of life and life. Adequate patient selection is a prerequisite for effective trimodal therapy. We summarize the components of organ-preserving treatment, including radiation therapy, its state-of-the-art technology, results and side effects. The results and toxicity of trimodal treatment are compared with those of radical cystectomy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Magyar onkologia
Magyar onkologia Medicine-Medicine (all)
CiteScore
0.60
自引率
0.00%
发文量
30
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信